https://industrynews.diagnostics.siemens.com/ArticleDetail.asp?site=global&ID=65668
Merck & Co. Inc. entered into a definitive agreement to buy SmartCells Inc., a privately held firm that is developing a glucose-responsive insulin formulation for the treatment of diabetes.
Merck & Co. Inc. entered into a definitive agreement to buy SmartCells Inc., a privately held firm that is developing a glucose-responsive insulin formulation for the treatment of diabetes.
